Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 339

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 339
---
1) | Values in millions of US dollars. |

| (2) | Corresponding Enterprise Value multiples in tables below. |

| (3) | Source: S&P Capital IQ. |

| Date     |     | Target                                                             |     | Buyer / Investor                           |     | Enterprise 
   Value($) |     | Sales    
 (TTM)($) |     | EBITDA   
 (TTM)($) |     | EBIT     
 (TTM)($) |
| 07/23/24 |     | Aprogen Biologics Inc. (KOSE:A003060)                              |     | —                                          |     |      228.6 |     | 3.6x     |     | 8.3x     |     | 18.5x    |
| 07/08/24 |     | Grifols, S.A. (BME:GRF)                                            |     | Brookfield Capital Partners (Uk) Limited   |     |   18,663.8 |     | 2.6x     |     | 13.6x    |     | 18.3x    |
| 06/20/24 |     | Range Impact, Inc. (OTCPK:RNGE)                                    |     | Continental Heritage Holding Company LLC   |     |       41.6 |     | 2.1x     |     | 12.2x    |     | 31.0x    |
| 06/14/24 |     | Fancl Corporation (TSE:4921)                                       |     | Kirin Holdings Company, Limited (TSE:2503) |     |    2,089.9 |     | 3.1x     |     | 21.1x    |     | 28.1x    |
| 03/12/24 |     | Navamedic ASA (OB:NAVA)                                            |     | —                                          |     |       61.4 |     | 1.2x     |     | 12.1x    |     | 15.7x    |
| 02/22/24 |     | Comvita Limited (NZSE:CVT)                                         |     | —                                          |     |      112.8 |     | 0.8x     |     | 14.5x    |     | 377.3x   |
| 02